TELA Bio (TELA) Shareholder's Equity Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.70% |
| Dec 31, 2025 | -77.82% |
| Sep 30, 2025 | 124.82% |
| Jun 30, 2025 | 220.00% |
| Mar 31, 2025 | 25.99% |
| Dec 31, 2024 | 50.72% |
| Sep 30, 2024 | -120.53% |
| Jun 30, 2024 | -92.83% |
| Mar 31, 2024 | 357.94% |
| Dec 31, 2023 | 31.99% |
| Sep 30, 2023 | 31.12% |
| Jun 30, 2023 | 2,694.36% |
| Mar 31, 2023 | -68.71% |
| Dec 31, 2022 | -28.82% |
| Sep 30, 2022 | -15.97% |
| Jun 30, 2022 | -104.41% |
| Mar 31, 2022 | -75.92% |
| Dec 31, 2021 | -59.01% |
| Sep 30, 2021 | -50.78% |
| Jun 30, 2021 | -44.85% |
| Mar 31, 2021 | 72.08% |
| Dec 31, 2020 | 58.34% |
| Sep 30, 2020 | 135.12% |
| Jun 30, 2020 | 141.24% |
| Mar 31, 2020 | 116.62% |
| Dec 31, 2019 | 122.46% |
| Sep 30, 2019 | -24.78% |